AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 124 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $15,000 | -37.5% | 7,618 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -90.3% | 7,618 | -87.3% | 0.00% | -100.0% |
| Q1 2022 | $248,000 | -55.4% | 60,036 | -48.4% | 0.00% | -50.0% |
| Q4 2021 | $556,000 | +16.3% | 116,446 | +29.5% | 0.00% | 0.0% |
| Q3 2021 | $478,000 | -45.9% | 89,939 | -47.9% | 0.00% | -33.3% |
| Q2 2021 | $883,000 | +65.4% | 172,560 | +117.4% | 0.00% | +50.0% |
| Q1 2021 | $534,000 | +1171.4% | 79,383 | +627.4% | 0.00% | – |
| Q3 2020 | $42,000 | -19.2% | 10,914 | 0.0% | 0.00% | – |
| Q2 2020 | $52,000 | -66.9% | 10,914 | -75.7% | 0.00% | -100.0% |
| Q1 2020 | $157,000 | -27.6% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $217,000 | +65.6% | 45,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $131,000 | -59.4% | 45,000 | 0.0% | 0.00% | -50.0% |
| Q2 2019 | $323,000 | -0.6% | 45,000 | +96.3% | 0.00% | +100.0% |
| Q1 2019 | $325,000 | – | 22,927 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |